These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Greinix HT; Reiter E; Keil F; Fischer G; Lechner K; Dieckmann K; Leitner G; Schulenburg A; Hoecker P; Haas OA; Knoebl P; Mannhalter C; Fonatsch C; Hinterberger W; Kalhs P Bone Marrow Transplant; 1998 Apr; 21(7):673-8. PubMed ID: 9578306 [TBL] [Abstract][Full Text] [Related]
26. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959 [TBL] [Abstract][Full Text] [Related]
27. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings. Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562 [TBL] [Abstract][Full Text] [Related]
28. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases]. Gratwohl A Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266 [TBL] [Abstract][Full Text] [Related]
29. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502 [TBL] [Abstract][Full Text] [Related]
30. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harrousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC Bone Marrow Transplant; 1996 Nov; 18(5):921-9. PubMed ID: 8932846 [TBL] [Abstract][Full Text] [Related]
31. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting]. Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of severe acquired aplastic anemia]. Jacobsen N Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation (1958-1978) : conditioning and graft-versus-host disease, indications in aplasias and leukemias. Mathe G; Schwarzenberg L Pathol Biol (Paris); 1979 Jun; 27(6):337-43. PubMed ID: 159426 [TBL] [Abstract][Full Text] [Related]
34. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [TBL] [Abstract][Full Text] [Related]
35. [HLA and bone marrow transplantation (BMT) (author's transl)]. Goldmann SF Klin Padiatr; 1981 May; 193(3):266-71. PubMed ID: 7021987 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic bone marrow transplantation as a therapeutic modality for hematological disorders: a report based on 39 cases. Naohara T; Hashino S; Masauji N; Matsuura A; Ohizumi H; Kobayashi N; Morii K; Kiyama Y; Saitoh M; Higa T Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1199-207. PubMed ID: 7868058 [TBL] [Abstract][Full Text] [Related]
38. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. Drobyski WR; Pelz C; Kabler-Babbitt C; Hessner M; Baxter-Lowe LA; Keever-Taylor CA Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386 [TBL] [Abstract][Full Text] [Related]
39. Marrow transplantation in aplastic anemia and leukemia. Weiden PL; Thomas ED; Storb R; Fefer A; Neiman PE; Clift RA; Buckner CD; Lerner KG Compr Ther; 1976 Apr; 2(4):57-62. PubMed ID: 4261 [TBL] [Abstract][Full Text] [Related]
40. [Bone marrow allograft in adults hemopathies. The Team of the Sterile Unit]. Debusscher L Rev Med Brux; 1992 May; 13(5):160-6. PubMed ID: 1609190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]